Turnstone Biologics Announces Research Collaboration with Moffitt Cancer Center to Advance Novel TIL Immunotherapies for Solid Tumor Indications November 29, 2021
Adagene Announces FDA Clearance of IND for Phase 1b/2 Trial of Anti-CTLA-4 Monoclonal Antibody ADG116 in Combination Therapy with Anti-PD-1 Antibody Pembrolizumab November 29, 2021
Verve Therapeutics Appoints Allison Dorval, Experienced Financial Executive, as Chief Financial Officer November 29, 2021
Ultragenyx Announces Additional Positive Multi-Year Durability Data from Phase 1/2 AAV Gene Therapy Studies November 29, 2021
Cloud R&D developer Benchling picks up second nine-figure venture capital haul this year November 19, 2021
Tempest Announces First Patient Dosed with TPST-1495 in Combination with Pembrolizumab November 18, 2021
OTA Insight books $80M for its hospitality business intelligence tools, used by 55K hotel properties globally November 18, 2021
Owkin becomes ‘unicorn’ with $180m investment from Sanofi and four new collaborative projects November 18, 2021
Orchard Therapeutics Announces New England Journal of Medicine Publication of Interim Proof-of-concept Study Results of OTL-203 for Hurler Syndrome November 18, 2021
WellAir Launches New Air Cleaning Device That Is 99.9% Effective Against Indoor Airborne Pathogens November 17, 2021